Q32 Bio
QTTB
QTTB
59 hedge funds and large institutions have $15.9M invested in Q32 Bio in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 10 closing their positions.
Holders
59
Holders Change
-3
Holders Change %
-4.84%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
19
Closed
10
Calls
$41K
Puts
$1K
Net Calls
+$40K
Net Calls Change
+$1K
Top Buyers
| 1 |
1
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$43.8K |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$9.58K |
| 3 |
3
Squarepoint
New York
|
$9.03K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$383K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$14.5K |
Top Sellers
| 1 |
1
JPMorgan Chase & Co
New York
|
$844 |
| 2 |
2
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$0 |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$638K |
| 4 |
4
Morgan Stanley
New York
|
$11.5K |
| 5 |
5
BlackRock
New York
|
$980K |
